Company intelligence / Profile preview
Voyager Therapeutics
Cambridge or Lexington*, Massachusetts, United Statesvoyagertherapeutic.gcs-web.com ↗
- Ownership
- Public · VYGR
- Employees
- ~172
- Development stage
- Phase 1
01
Overview
Voyager Therapeutics has demonstrated robust preclinical results with its TRACER-derived AAV capsids enabling efficient CNS delivery after intravenous dosing. In non-human primate models, their tau-silencing program achieved significant reductions in tau mRNA and protein levels across the brain. The SOD1 ALS program also showed strong target engagement and safety in NHPs. Multiple programs are advancing toward IND filings in the next one to two years[4][7].
- Therapeutic areas
- Neurology
- Modalities
- Gene therapy (AAV-based)Vectorized antibodies (gene-delivered mAbs)RNAi/siRNA gene silencing
- Industry
- Biotech
02
Drug pipeline
24 assets23 more assets in the full pipeline.
Request access →03
Financials
- Market cap
- $196.4M
- Total revenue
- $3.2M
- Enterprise value
- $112.6M
Beyond the preview
Go deeper on Voyager Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Voyager Therapeutics.